ISSN: 1354-3784
Journal Home
Journal Guideline
Expert Opinion on Investigational Drugs Q1 Unclaimed
Expert Opinion on Investigational Drugs is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 117. It has a price of 4000 €. It has an SJR impact factor of 1,414 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,414.
Expert Opinion on Investigational Drugs focuses its scope in these topics and keywords: treatment, potential, therapeutic, development, drug, inhibitors, androgenetic, inhibitor, investigational, agonists, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
![Scopus Scopus](https://countryofpapers.com/img/indexedin/logo_sjr_bw.png)
![WOS WOS](https://countryofpapers.com/img/indexedin/jcr_bw.png)
4000 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,414
SJR Impact factor117
H Index108
Total Docs (Last Year)354
Total Docs (3 years)8144
Total Refs1698
Total Cites (3 years)322
Citable Docs (3 years)4.77
Cites/Doc (2 years)75.41
Ref/DocOther journals with similar parameters
Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1
Compare this journals
Aims and Scope
Best articles by citations
New therapies and vaccines for bacterial meningitis
View moreAlvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia
View morePeroxisome proliferator-activated receptor ligands in atherosclerosis
View moreThe future of obesity: new drugs versus lifestyle interventions
View morePharmacology and clinical trial results of lanoteplase in acute myocardial infarction
View moreCiclesonide: a novel inhaled corticosteroid
View moreCT-2103: emerging utility and therapy for solid tumours
View moreThe therapeutic potential of monoclonal antibodies against respiratory syncytial virus
View moreThe therapeutic potential of Na+and Ca2+channel blockers in pain management
View moreApoptosis regulating proteins as targets of therapy for haematological malignancies
View morePlatelet substitutes and novel platelet products
View moreDNA minor groove binding ligands: a new class of anticancer agents
View moreAvanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction
View moreThe potential of retro-inverso peptides as synthetic vaccines
View moreAlzheimer?s disease - current trends in basic and clinical research. Highlights from the 16th ECNP
View moreExperimental and emerging therapies for sepsis and septic shock
View moreNew strategies for the prevention and treatment of Helicobacter pylori infection
View moreErratum
View moreIntegrin antagonists as potential therapeutic options for the treatment of Crohn's disease
View moreCampylobacter vaccine development:a key to controlling enteric diseases
View moreModifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors
View moreAddenda
View moreNew investigational antifungal agents for treating invasive fungal infections
View moreCelecoxib for the treatment of atherosclerosis
View more
Comments